09 December 2024
09 December 2024
Research shows an average weight loss of just 5% could save an annual $153bn in medical fees and lost productivity.
Shares in WuXi AppTec, one of those implicated in the Chinese biotech blacklisting legislation, surged following the omission.
The construction for the expansion is scheduled to begin in 2025.
The new FDA guidance outlines how surrogate or intermediate clinical endpoints can support accelerated approval.
The $16.5bn acquisition agreement was first announced in February 2024.
Regulatory reviews based on the trial are underway in countries and regions including Japan and the EU.
CGTs have faced challenges attracting investment due to the large amount of capital required to manufacture CGTs.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
